Picture of Revelation Biosciences logo

REVB — Revelation Biosciences News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Brief: Gemini Induces Pharmacologic Activity And Related Physiologic Changes In Multiple Preclinical Studies

Oct 12 (Reuters) - Revelation Biosciences Inc  REVB.O :
    * GEMINI INDUCES PHARMACOLOGIC ACTIVITY AND RELATED
PHYSIOLOGIC
CHANGES IN MULTIPLE PRECLINICAL STUDIES
    * REVELATION BIOSCIENCES INC - KEY BIOMARKER ACTIVITY
CONFIRMED
FOR EVALUATION IN UPCOMING PHASE 1 STUDY

Source text for Eikon:  ID:nBw46VyQda 
Further company coverage:  REVB.O 

 ((Reuters.Briefs@thomsonreuters.com))

Recent news on Revelation Biosciences

See all news